Table 1 Characteristics and clinical data of the patients.
Variables | Robot group (n = 45) | Frame group (n = 86) | P-value |
|---|---|---|---|
Demographics | |||
Male sex, n(%)‡ | 38(84.4) | 64(74.4) | 0.189 |
Age (y), mean ± SD # | 54 ± 13 | 53 ± 12 | 0.681 |
Clinical history | |||
SBP(mmHg), mean ± SD # | 169 ± 24 | 168 ± 26 | 0.799 |
DBP(mmHg), mean ± SD # | 98 ± 18 | 99 ± 20 | 0.727 |
Diabetes mellitus, n(%)§ | 3(6.7) | 8(9.3) | 0.853 |
Anticoagulant/antiplatelet, n(%)§ | 2(4.4) | 8(9.3) | 0.517 |
GCS, median[IQR] † | 9[7–14] | 10[8–13] | 0.876 |
Laboratory test | |||
Blood type, n(%)§ | 0.472 | ||
Type A | 9(20.0) | 24(27.9) | |
Type B | 14(31.1) | 18(20.9) | |
Type O | 17(37.8) | 37(43.0) | |
Type AB | 5(11.1) | 7(8.1) | |
Hemoglobin, mean ± SD # | 143 ± 17 | 142 ± 20 | 0.912 |
NLR, median[IQR] † | 5.9[3.0–11.0] | 8.3[4.3–14.8] | 0.047** |
Platelets, median[IQR] † | 207[166–245] | 204[162–246] | 0.915 |
PT, mean ± SD # | 11.0 ± 0.8 | 11.7 ± 1.1 | < 0.001** |
APTT, mean ± SD # | 29.0 ± 3.1 | 29.1 ± 3.2 | 0.913 |
Hematoma characteristics | |||
Left hemisphere, n(%)‡ | 22(48.9) | 44(51.2) | 0.805 |
IVH, n(%)‡ | 18(40.0) | 26(30.2) | 0.261 |
Volume(ml), median[IQR] † | 29.0[23.0-35.2] | 33.3[25.5–44.0] | 0.130 |
Surface area(cm2), median[IQR] † | 68.0[56.5–86] | 73.0[58.8–98.5] | 0.274 |
Onset-to-surgery time, n(%)† | 0.494 | ||
6–12 h | 22(48.9) | 33(38.4) | |
12–18 h | 9(20.0) | 21(24.4) | |
18–24 h | 2(4.4) | 13(15.1) | |
1–2days | 10(22.2) | 12(21.8) | |
2–3days | 2(4.4) | 4(4.7) | |
